Skip to content

Clinical trials

Phase 2 Hodgkin Disease trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Phase 2 Status: Unknown status Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20093
20101
20115
20131
20151
20161
20174
20185
20194
20203
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital3
University College, London3
Cancer Research UK2
Herbert Irving Comprehensive Cancer Center2
Hospital Universitario Dr. Jose E. Gonzalez2
Northwestern University2
Sheba Medical Center2
American Scitech International1
Armando Santoro, MD1
Auxilio Mutuo Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease41
Lymphoma12
Lymphoma, Non-Hodgkin11
Leukemia, Lymphocytic, Chronic, B-Cell8
Recurrence8
Leukemia6
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Multiple Myeloma6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.